Concepedia
Statistics
Publications
7
Citations
327
H-Index
Active since
2007
Affiliations
Rutgers Cancer Institute(Current)
Rutgers, The State University of New Jersey
Fred Hutch Cancer Center
Yale Cancer Center
Huntsman Cancer Institute
Janice M. Mehnert is an author at Rutgers Cancer Institute specializing in oncology, medicine, and molecular oncology.
Publications per year
2007–2022
Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial
Alain P. Algazi, Megan Othus, Adil Daud et al. · Nature Medicine · 2020 · 111 citations · Full text
Medicine, Oncology, Pharmacotherapy +14
Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays
Janice M. Mehnert, Mary M. McCarthy, Lucia B. Jilaveanu et al. · Human Pathology · 2009 · 103 citations
Medicine, Molecular Biology, Oncology +14
<i>BRAF</i> Fusion as a Novel Mechanism of Acquired Resistance to Vemurafenib in <i>BRAF</i>V600E Mutant Melanoma
Atul Kulkarni, Husam Al-hraishawi, Srilatha Simhadri et al. · Clinical Cancer Research · 2017 · 61 citations
Medicine, Oncology, Pharmacology +17
SWOG S1320: A randomized phase II trial of intermittent versus continuous dosing of dabrafenib and trametinib in BRAF<sup>V600E/k</sup> mutant melanoma.
Alain P. Algazi, Megan Othus, Adil Daud et al. · Journal of Clinical Oncology · 2015 · 16 citations
Medicine, Pharmacology, Pharmacotherapy +15
Genomic and Transcriptomic Analyses of NF1-Mutant Melanoma Identify Potential Targeted Approach for Treatment
George Jour, Irineu Illa-Bochaca, Milad Ibrahim et al. · Journal of Investigative Dermatology · 2022 · 13 citations · Full text
Medicine, Molecular Biology, Oncology +17
1–5 of 7